Furthermore, the overexpression of WNT5A and WNT16 correlated with worse overall survival in glioma patients, whereas high expression of WNT5B, WNT10B, and WNT3 correlated with better overall survival probability. This evidence concerns the gene WNT10B and central nervous system cancer.